David Taggart

Showing 1-12 of 12 articles

Prognostic performance of the Society of Thoracic Surgeons risk score in patients with left main coronary artery disease undergoing revascularisation: a post hoc analysis of the EXCEL trial

Thuijs D, Habib R, Head S, Puskas J, Taggart D, Stone G, Zhang Z, Serruys P, Sabik J, Kappetein A

May 20, 2020 | 10.4244/EIJ-D-19-00417

FFR for CABG: not ready for prime time

Gaudino M, Di Franco A, Taggart D

December 6, 2019 | 10.4244/EIJV15I11A177

Does an occluded RCA affect prognosis in patients undergoing PCI or CABG for left main coronary artery disease? Analysis from the EXCEL trial

Chen S, Karmpaliotis D, Redfors B, Shlofmitz E, Ben-Yehuda O, Crowley A, Mehdipoor G, Puskas J, Kandzari D, Banning A, Morice M, Taggart D, Sabik J, Serruys P, Kappetein A, Stone G

August 9, 2019 | 10.4244/EIJ-D-19-00263

Absence of proof or proof of absence? The risk of underpowered studies in cardiovascular medicine

Gaudino M, Benedetto U, Taggart D

September 20, 2018 | 10.4244/EIJV14I7A126

What is new in the armamentarium of coronary surgeons to compete with PCI?

Gaudino M, Taggart D

July 20, 2018 | 10.4244/EIJV14I4A69

Coronary interventions

Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial

Kappetein A, Serruys P, Sabik J, Leon M, Taggart D, Morice M, Gersh B, Pocock S, Cohen D, Wallentin L, Ben-Yehuda O, Van Es G-A, Simonton C, Stone G

September 18, 2016 | 10.4244/EIJV12I7A141

Coronary interventions

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease

Escaned J, Banning A, Farooq V, Echavarría-Pinto M, Onuma Y, Ryan N, Cavalcante R, Campos C, Stanetic B, Ishibashi Y, Suwannasom P, Kappetein A, Taggart D, Morel M, Van Es G-A, Serruys P

June 10, 2016 | 10.4244/EIJV12I2A36

2014 ESC/EACTS Guidelines on myocardial revascularization

Windecker S, Kolh P, Alfonso F, Collet J, Cremer J, Falk V, Filippatos G, Hamm C, Head S, Jüni P, Kappetein A, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann F, Richter D, Schauerte P, Uva M, Stefanini G, Taggart D, Torracca L, Valgimigli M, Wijns W, Witkowski A

January 22, 2015 | 10.4244/EIJY14M09_01

Numbers needed to treat (lives!) and numbers needed to save (money)

Ribichini F, Taggart D, Vassanelli C

June 28, 2013 | 10.4244/EIJV9I2A28

Does a hybrid approach to multivessel revascularisation really make sense?

Taggart D

March 22, 2013 | 10.4244/EIJV8I11A189

Does prior PCI influence the clinical outcome of CABG?

Taggart D

May 19, 2009

Drug eluting stents in left main stem stenosis: patients will pay the price

Taggart D

February 20, 2007

Latest news

EDITORIAL

A State-of-the Art and Mini Focus on Intracoronary OCT; Thrombectomy for Acute Ischaemic Stroke; and more…

June 11, 2021

NEW

Intracoronary OCT: State of the Art and Future Directions

Ziad A. Ali et al.

June 11, 2021

PCR Companion attending EuroPCR? Activate your free subscription!

May 28, 2021

TRIALS BOOK

Access the full Trials Book 2021

(Thanks to the support of Biotronik)

May 18, 2021

EDITORIAL

The Complex Relationship Between Geometrical and Functional Results of PCI

Nieves Gonzalo et al.

June 17, 2021

EDITORIAL

Fruitful New Data on Left Main PCI: the LEMON Study

Maria D. Radu Juul Jensen et al.

June 11, 2021

JAA

This Week's JAA's: ABSORB DAPT, OFR in predicting post-PCI FFR and more...